Skip to main content

Table 2 Summary of antibodies which can be used in differential diagnosis of ACA and SCC

From: Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

  ACA SCC
HNF-1β ++ -
(75%) (2%)
p63/p40 −+ +++
(7% / 4%) (100%)
CEA +++ +++
(86%) (91%)
ER +− +−
(16%) (11%)
PR −+ -
(9%) (1%)
D2-40 - ++
(0%) (54%)
  1. ACA - adenocarcinoma; SCC - squamous cell carcinoma.
  2. In brackets is a percentage of positive cases in our study.